PwC has expanded its deals practice with the appointment of Raj Agrawal and Wendy Britten as partners in its transaction services team.
Agrawal joins from pharmaceutical firm Novartis, and will lead the development of a team focused on value creation in the life sciences sector working with large pharma and private equity clients.
Britten rejoins PwC from cyber security consultancy S-RM where she held the role of chief financial officer.
In addition to the new appointments, a further 17 new equity partners have been promoted in the deals practice across its four business units – business restructuring services, corporate finance, forensics services and transactions services.
Lucy Stapleton, UK head of deals, said: “I am delighted to welcome Raj to our team and welcome Wendy back to our PwC team again! Both bring skills and experience that will add tremendous value to our practice and our offering to clients at a time when we are seeing an increased level of activity from private equity investors in the market.
“We see significant growth potential in the consumer healthcare and pharma/life sciences markets and investing in top talent is absolutely critical to our growth ambitions.”